Modi Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Cytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
Cytospire Therapeutics develops multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s immune system. Its platform targets gamma delta T cells to generate anti tumour immune responses for patients with cancer and other diseases.
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs
Ignota Labs applies AI-driven drug discovery to rescue and redevelop failed drug candidates, identifying and resolving safety issues so promising therapies can be revived and progressed back into clinical development.
- 2(12 months)
- modivc.com
- Update Information
More venture news
- 14 Jul 2026
ValarianValarian raises a £37m Series A round led by NEA to provide sovereign control over AI workloads
Series ADefence - 14 Jul 2026
GridcogGridcog secures £7m in a Series A round led by ABB for its energy flexibility modelling platform
Series AEnergy - 14 Jul 2026
VelocityVelocity announces £28m Series A led by Dragonfly and FirstMark for stablecoin treasury and settlement infrastructure
Series AFintech
